109 results
Page 2 of 6
8-K
EX-99.1
i1jd9jczvfht
16 Aug 21
AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
36l 51y0b
14 Jul 21
AcelRx to receive up to approximately $55 million in combined up-front and sales-based milestone payments for DZUVEO licensing agreement
4:01pm
8-K
EX-10.1
j8jctp6
17 Jun 21
Departure of Directors or Certain Officers
5:11pm
424B5
pm2221 fpcki
21 Jan 21
Prospectus supplement for primary offering
5:29pm
424B5
6seffl3mb0e
19 Jan 21
Prospectus supplement for primary offering
4:31pm
S-8
EX-99.1
29pdqkyr ft03z
16 Jun 20
Registration of securities for employees
4:52pm
S-8
EX-99.3
kqwk 4fz5z8mdn5pc
16 Jun 20
Registration of securities for employees
4:52pm
425
lj1ox
11 May 20
Business combination disclosure
4:06pm
8-K
EX-99.1
d2bxjo
11 May 20
AcelRx Pharmaceuticals Reports First Quarter 2020 Financial Results
4:05pm
424B3
8h4p q5cq9
24 Apr 20
Prospectus supplement
4:05pm